CDKN2A variants in a population-based sample of queensland families with melanoma

被引:159
|
作者
Aitken, J [1 ]
Welch, J [1 ]
Duffy, D [1 ]
Milligan, A [1 ]
Green, A [1 ]
Martin, N [1 ]
Hayward, N [1 ]
机构
[1] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源
关键词
D O I
10.1093/jnci/91.5.446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mutations in the CDKN2A gene confer susceptibility to cutaneous malignant melanoma (CMM); however, the population incidence of such mutations is unknown, Polymorphisms in CDKN2A have also been described, but it is not known whether they influence melanoma risk, We investigated the association of CDKN2A mutations and polymorphisms nifh melanoma risk in a population-based sample of families ascertained through probands with melanoma, Methods: The 482 Queensland, Australia, families in our sample were characterized previously as having high, intermediate, or low family risk of CMM. Unrelated individuals (n = 200 families/individuals) drawn from the Australian Twin Registry served as control subjects. For individuals in the high-risk group, the entire CDKN2A gene coding region was screened for mutations by use of the polymerase chain reaction, agarose gel electrophoresis, allele-specific oligonucleotide (ASO) hybridization, and single-strand conformation polymorphism analysis, The intermediate- and low-risk families and control subjects were analyzed by ASO hybridization for a total of six recurring mutations as well as for polymorphisms at nucleotides (Nts) 442, 500, and 540, Results: CDKN2A mutations were found only in the high-risk families (nine [10.3%] of 87), The prevalence of the Nt500G (guanosine) polymorphism increased linearly with increasing familial risk (two-sided P = .02) and was highest in the nine (primarily Celtic) families with CDKN2A mutations. After adjustment for ethnic origin, the relationship between risk group and the frequency of the Nt500G allele was weakened (P = .25); however, there was no relationship between ethnic origin and Nt500-polymorphism frequency among the control subjects. Conclusions: CDKN2A mutations are rare in this population (approximately 0.2% of all melanoma cases in Queensland) and appear to be associated with melanoma in only the most affected families, The Nt500G allele appears to be associated with familial risk, but this association probably reflects Celtic ancestry.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [11] Mutation analysis of the cdkn2a promoter in australian melanoma families
    Pollock P.A.
    Stark M.
    Palmer J.M.
    Walters M.K.
    Martin N.G.
    Green A.C.
    Hayward N.K.
    Nature Genetics, 2001, 27 (Suppl 4) : 80 - 80
  • [12] Intronic sequence variants of the CDKN2A gene in melanoma pedigrees
    Harland, M
    Taylor, CF
    Bass, S
    Churchman, M
    Randerson-Moor, JA
    Holland, EA
    Mann, GJ
    Bishop, DT
    Bishop, JAN
    GENES CHROMOSOMES & CANCER, 2005, 43 (02): : 128 - 136
  • [13] CDKN2A mutations and melanoma risk in the Icelandic population
    Goldstein, A. M.
    Stacey, S. N.
    Olafsson, J. H.
    Jonsson, G. F.
    Helgason, A.
    Sulem, P.
    Sigurgeirsson, B.
    Benediktsdottir, K. R.
    Thorisdottir, K.
    Ragnarsson, R.
    Kjartansson, J.
    Kostic, J.
    Masson, G.
    Kristjansson, K.
    Gulcher, J. R.
    Kong, A.
    Thorsteinsdottir, U.
    Rafnar, T.
    Tucker, M. A.
    Stefansson, K.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (05) : 284 - 289
  • [14] Mutation analysis of the CDKN2A promoter in Australian melanoma families
    Pollock, PM
    Stark, MS
    Palmer, JM
    Walters, MK
    Aitken, JF
    Martin, NG
    Hayward, NK
    GENES CHROMOSOMES & CANCER, 2001, 32 (01): : 89 - 94
  • [15] CDKN2A and CDK4 variants in Latvian melanoma patients:: analysis of a clinic-based population
    Pjanova, Dace
    Engele, Ludmila
    Randerson-Moor, Juliette A.
    Harland, Mark
    Bishop, D. Timothy
    Bishop, Julia A. Newton
    Taylor, Claire
    Debniak, Tadeusz
    Lubinski, Jan
    Kleina, Regina
    Heisele, Olita
    MELANOMA RESEARCH, 2007, 17 (03) : 185 - 191
  • [16] Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations
    Goldstein, AM
    Landi, MT
    Tsang, S
    Fraser, MC
    Munroe, DJ
    Tucker, MA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) : 2208 - 2212
  • [17] Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases
    Aoude, Lauren G.
    Gartside, Michael
    Johansson, Peter
    Palmer, Jane M.
    Symmons, Judith
    Martin, Nicholas G.
    Montgomery, Grant W.
    Hayward, Nicholas K.
    TWIN RESEARCH AND HUMAN GENETICS, 2015, 18 (02) : 126 - 133
  • [18] Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
    Cust, Anne E.
    Harland, Mark
    Makalic, Enes
    Schmidt, Daniel
    Dowty, James G.
    Aitken, Joanne F.
    Agha-Hamilton, Chantelle
    Armstrong, Bruce K.
    Barrett, Jenny H.
    Chan, May
    Chang, Yu-Mei
    Gascoyne, Joanne
    Giles, Graham G.
    Holland, Elizabeth A.
    Kefford, Richard F.
    Kukalizch, Kairen
    Lowery, Johanna
    Randerson-Moor, Juliette A.
    Schmid, Helen
    Taylor, Claire F.
    Whitaker, Linda
    Hopper, John L.
    Newton-Bishop, Julia A.
    Mann, Graham J.
    Bishop, D. Timothy
    Jenkins, Mark A.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (04) : 266 - 272
  • [19] Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants
    Overbeek, Kasper A.
    Rodriguez-Girondo, Mar D. M.
    Wagner, Anja
    van der Stoep, Nienke
    van den Akker, Peter C.
    Oosterwijk, Jan C.
    van Os, Theo A.
    van der Kolk, Lizet E.
    Vasen, Hans F. A.
    Hes, Frederik J.
    Cahen, Djuna L.
    Bruno, Marco J.
    Potjer, Thomas P.
    JOURNAL OF MEDICAL GENETICS, 2021, 58 (04) : 264 - 269
  • [20] Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations
    Liang, Xueying Sharon
    Pfeiffer, Ruth M.
    Wheeler, William
    Maeder, Dennis
    Burdette, Laurie
    Yeager, Meredith
    Chanock, Stephen
    Tucker, Margaret A.
    Goldstein, Alisa M.
    Yang, Xiaohong R.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2062 - 2066